2-BENZIMIDAZOLEPROPIONIC ACID manufacturers
- Procodazole
-
- $30.00 / 500mg
-
2026-03-13
- CAS:23249-97-0
- Min. Order:
- Purity: 98.00%
- Supply Ability: 10g
- Procodazole
-
- $30.00 / 500mg
-
2026-03-13
- CAS:23249-97-0
- Min. Order:
- Purity: 98.00%
- Supply Ability: 10g
- Procodazole
-
- $30.00 / 500mg
-
2025-04-28
- CAS:23249-97-0
- Min. Order:
- Purity: 99.61%
- Supply Ability: 10g
|
| | 2-BENZIMIDAZOLEPROPIONIC ACID Basic information |
| | 2-BENZIMIDAZOLEPROPIONIC ACID Chemical Properties |
| Melting point | 229-231 °C (dec.)(lit.) | | Boiling point | 497.9±28.0 °C(Predicted) | | density | 1.367±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : ≥ 30 mg/mL (157.73 mM) | | pka | 3.98±0.10(Predicted) | | form | Solid | | color | White to off-white | | Merck | 13,7851 | | InChI | InChI=1S/C10H10N2O2/c13-10(14)6-5-9-11-7-3-1-2-4-8(7)12-9/h1-4H,5-6H2,(H,11,12)(H,13,14) | | InChIKey | XYWJNTOURDMTPI-UHFFFAOYSA-N | | SMILES | C1(CCC(O)=O)NC2=CC=CC=C2N=1 | | CAS DataBase Reference | 23249-97-0(CAS DataBase Reference) |
| Hazard Codes | Xn,Xi | | Risk Statements | 20/21/22-36/37/38 | | Safety Statements | 26-37/39 | | WGK Germany | 3 | | RTECS | UE7480000 | | HazardClass | IRRITANT | | HS Code | 29332990 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Dermal
Acute Tox. 4 Inhalation
Acute Tox. 4 Oral
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3 |
| | 2-BENZIMIDAZOLEPROPIONIC ACID Usage And Synthesis |
| Uses | immune stimulant | | Uses | 2-Benzimidazolepropionic acid is suitable reagent for use in the method of generation of monoclonal antibodies against very small drug hapten, 5-benzimidazolecarboxylic acid by in vivo immunisation method and an in vitro immunisation procedure. It may be used in the synthesis of cytidine derivatives. | | Definition | ChEBI: Procodazole is a member of benzimidazoles. | | General Description | 2-Benzimidazolepropionic acid is a 2-(4-thiazolyl)benzimidazole analog. 2-Benzimidazolepropionic acid is a 2-substituted benzimidazole ligand and its dissociation constant has been evaluated. 2-Benzimidazolepropionic acid is reported to possess active antimarial activity. | | in vivo | Procodazole (50 mg per dog, p.o., once daily for 28 days) can significantly reduce the parasite burden in Beagles infected with Toxocara canis and enhance their resistance to Toxocara canisinfection[1]. | Animal Model: | Three-month-old Beagle puppies infected with 3000 embryonated Toxocara canis eggs[2] | | Dosage: | 50 mg per dog | | Administration: | Oral gavage (p.o.), once daily for 28 days | | Result: | Reduced the number of worms significantly in the treated group compared to the untreated group, with a 63.8% reduction in worm burden. |
| | IC 50 | CA Ⅸ: 8.35 μM (IC50) |
| | 2-BENZIMIDAZOLEPROPIONIC ACID Preparation Products And Raw materials |
|